Latesh Lad - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Latesh Lad

Showing results (31-40 of 34) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 34 results.

Proceedings of the National Academy of Sciences of the United States of America|February 20, 2010

Antitumor activity of an allosteric inhibitor of centromere-associated protein-EKenneth W Wood, Latesh Lad, Lusong Luo, et al.

Journal of Medicinal Chemistry|October 1, 2025

Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure ProphylaxisEda Canales, Winston Tse, Scott D Schroeder, et al.

ACS Medicinal Chemistry Letters|June 6, 2014

Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295Xiangping Qian, Andrew McDonald, Han-Jie Zhou, et al.

Nature|July 3, 2020

Clinical targeting of HIV capsid protein with a long-acting small moleculeJohn O Link, Martin S Rhee, Winston C Tse, et al.

Pageof 4

Search research articles

Showing results (31-40 of 34) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 34 results.

Proceedings of the National Academy of Sciences of the United States of America|February 20, 2010

Antitumor activity of an allosteric inhibitor of centromere-associated protein-EKenneth W Wood, Latesh Lad, Lusong Luo, et al.

Journal of Medicinal Chemistry|October 1, 2025

Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure ProphylaxisEda Canales, Winston Tse, Scott D Schroeder, et al.

ACS Medicinal Chemistry Letters|June 6, 2014

Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295Xiangping Qian, Andrew McDonald, Han-Jie Zhou, et al.

Nature|July 3, 2020

Clinical targeting of HIV capsid protein with a long-acting small moleculeJohn O Link, Martin S Rhee, Winston C Tse, et al.

Pageof 4